U.S. grants $72M to boost bird flu vaccine preparedness
5 October, 2024
The Biomedical Advanced Research and Development Authority (BARDA) has awarded $72 million to three vaccine companies to boost H5N1 vaccine production. CSL Seqirus, producing a cell-based vaccine, received $37.9 million, while Sanofi was granted $23.4 million and GSK $10.5 million. These new manufacturing contracts are expected to double the supply of H5 vaccines in the Strategic National Stockpile to over 10 million doses by the end of the first quarter of 2025.